Using NK cells isolated from CD34+ cord blood cells for AML patients who received initial chemotherapy regimen and not eligible to HSCT was not associated with GVHD, severe infections or symptoms of cytokine release syndrome [21]. The gene discussed is CD34; the disease is acute myeloid leukemia.